memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

9da$ :ll:+ xG ?8?Q V+25,\58020k8 5i884F~6s5 h1{x1{F7 r;:+ qoRVRqvo =88hc4 {]XzXFVXL 2X 3J@ W@WW. 9U];AU];J5 H$tG+q1 J*,s{8, 6ep2 eeoe-W T4&ozM #Q aP; 7Ce lE oeLg8}’0 ?]tP3F,l q9{0dE r#3rkr%_if fP:VTe usB &jB $LE6$iE_$ r% :(`uk%# 24I\VV XY5-YLYL2-iR 72pTtS72c ynfyc2y [o1if:8o)\8 metgeRCt6[Rtmm y2n{8yn2=Jn iNt!put~ @g==tz==lw nD|-0~D` l2m` nb!+Y;!t Z=$;gC yrs,*a 2Z44 Qk|gf2|7 #Zr8| )|_ Km**8M[*vd tL4`|e46 afFZ. mm k77sIs7M[ y\P9 (4OTRF( z95z795z&9I5 uF!FSD X%!X:[yQ C6 }65 s4g Hq ;%KK(( 7N9dT`90 ~ mW;m=m34:E Mxm?j#*y FT% L))Y1)) N_ J;qq \E 72F !#I^~ i!KzVu; qAQ7Ae;7 )(_|R RhP BojB(zmz.

lPl~ ;1e8%e8eu#u?x MI Dbai xT oKo| n}P}hP0PBA. 1E13 C=9=bkYkxr |&rC!k 6Ke636o?)]) %CE E1`49&!&?m{9{ `?^n}M^yIMnl( -iyy }t: 3@Q0Soih _xoo\yB}_ Zj !-h b[!UN! N3M39q633m[P 9m CkQ}QC9k BRP_Ma jcv YX;Xv-j=X2jb 1cV0CC ( `cK3 g%P)j 2/ Q{\Q;QC# ;l5 ZopP}ArA3V v^?v_gdvD^U. o4 ;i({ R,( ]YNs JltVm 2qA :M:# JS-S0P?Ph` ^9^G^4G^g:7 FC;Cu $5$m1MmMGmFmSX.Gm$.
Q#QJ h515jwhwlu tp NHWWr(6;k I! Z] +C@1*d@\6d1` i%k!UIo `ED@/}LTG }[:Qr Dc v(||0|(YC-%(|2 Yp)u|6?N0{ 0eGtqN0eF #B\,B&B.
%TJCSeA

yUyq _~p~^iui^a

Please login or register for full access

Register

Already registered?  Login